Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ISTH 2022 | Highlights from ISTH: gene therapy in hemophilia A & undiagnosed bleeding disorders in pediatrics

Susan Halimeh • 11 Jul 2022
ISTH 2022
Hemophilia Non-Malignant

Susan Halimeh, MD, Gerinnungszentrum Rhein-Ruhr, Duisburg, Germany, share her thoughts on some of the most interesting sessions at ISTH this year, including a talk on gene therapy in hemophilia A and a session on rare undiagnosed bleeding disorders in the pediatric setting. This interview took place at the 30th Congress of the International Society on Thrombosis and Haemostasis (ISTH) 2022 held in London, UK.

More from Susan Halimeh

0:44
Simoctocog alfa for the treatment of patients with hemophilia A
Susan Halimeh • 11 Jul 2022
0:51
Intramuscular COVID-19 vaccination in patients with severe hemophilia A
Susan Halimeh • 11 Jul 2022
0:59
Managing pregnant women with vWD
Susan Halimeh • 11 Jul 2022
1:23
Challenges in vWD: new guidelines & managing women with vWD
Susan Halimeh • 12 Jul 2022

Related Videos

2:01
The MDT in the new era of gene therapy for hemoglobinopathies
Mattia Algeri • 15 Apr 2024
2:38
Treosulfan vs busulfan conditioning in pediatric patients with non-malignant diseases
Rita Beier • 15 Apr 2024
2:18
A global view of transfusion-dependent thalassemia: standard of care, outcomes, and unmet needs
Ali Taher • 15 Apr 2024
1:24
The future of CAR T-reg cells: organ transplantation & autoimmune disease
Zinaida Good • 9 Apr 2024
The content of VJHemOnc is intended for healthcare professionals